|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.14 CAD | 0.00% |
|
+7.69% | +75.00% |
| 04-18 | Transcript : Kane Biotech Inc. - Special Call | |
| 04-15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
Kane Biotech Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was CAD 0.677617 million compared to CAD 0.565433 million a year ago. Net loss was CAD 1.2 million compared to CAD 1.11 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +75.00% | 13.51M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
KANE BIOTECH INC. 
